News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
824,292 Results
Type
Article (85257)
Company Profile (622)
Press Release (738413)
Section
Business (231844)
Career Advice (4090)
Deals (39621)
Drug Delivery (106)
Drug Development (90420)
Employer Resources (192)
FDA (17885)
Job Trends (17246)
News (394596)
Policy (39583)
Tag
Academia (2973)
Africa (1262)
Alliances (56333)
Alzheimer's disease (1242)
Approvals (17793)
Arizona (210)
Artificial intelligence (86)
Asia (48996)
Australia (8615)
Bankruptcy (392)
Best Places to Work (12247)
Biotechnology (437)
C2C Services and Suppliers (95111)
California (1987)
Canada (934)
Cancer (524)
Career advice (3497)
Cell therapy (140)
China (154)
Clinical research (70410)
Collaboration (150)
Colorado (80)
Compensation (82)
Connecticut (81)
COVID-19 (2753)
Cystic fibrosis (77)
Data (296)
Diabetes (90)
Diagnostics (6496)
Drug pricing (81)
Earnings (93521)
Employer resources (162)
Europe (111998)
Events (124972)
Executive appointments (152)
FDA (18099)
Florida (269)
Funding (149)
Gene therapy (105)
GLP-1 (616)
Government (5006)
Healthcare (20647)
Hotbed/Location (534575)
Illinois (319)
Indiana (160)
Infectious disease (2783)
Inflammatory bowel disease (102)
Interviews (805)
IPO (17484)
Job creations (5172)
Job search strategy (2849)
Kansas (100)
Layoffs (467)
Legal (10011)
Lung cancer (124)
Manufacturing (99)
Maryland (426)
Massachusetts (1694)
Medical device (14261)
Medtech (14266)
Mergers & acquisitions (21953)
Metabolic disorders (293)
Michigan (135)
Minnesota (235)
Neuroscience (1404)
New Jersey (605)
New York (606)
NextGen Class of 2024 (7622)
Non-profit (5052)
North Carolina (698)
Northern California (837)
Obesity (174)
Ohio (110)
Opinion (234)
Patents (75)
Pennsylvania (587)
People (63706)
Pharmaceutical (119)
Phase I (21619)
Phase II (30568)
Phase III (23098)
Pipeline (110)
Podcasts (75)
Postmarket research (3532)
Preclinical (9762)
Press Release (72)
Rare diseases (140)
Real estate (7361)
Recruiting (72)
Regulatory (25586)
Research institute (2633)
Resumes & cover letters (645)
South America (1641)
Southern California (759)
Startups (4271)
Texas (263)
United States (9238)
Vaccines (563)
Washington State (277)
Weight loss (166)
Date
Today (149)
Last 7 days (727)
Last 30 days (2407)
Last 365 days (40105)
2024 (27954)
2023 (42566)
2022 (53929)
2021 (58727)
2020 (57671)
2019 (51341)
2018 (39126)
2017 (37193)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36269)
2012 (38416)
2011 (38383)
2010 (39616)
There are 824,292 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Adbry® (tralokinumab-ldrm) Autoinjector Now Available for the Treatment of Adults with Moderate-to-Severe Atopic Dermatitis (AD) in the U.S.
September 17, 2024
·
8 min read
Press Releases
Nura Bio Closes Series A Financing with $68 Million in New Funds, Bringing Total Raised to $140+ Million
September 17, 2024
·
3 min read
Press Releases
Patritumab Deruxtecan Demonstrated Statistically Significant Improvement in Progression-Free Survival Versus Doublet Chemotherapy in Patients with Locally Advanced or Metastatic EGFR-Mutated Non-Small Cell Lung Cancer in HERTHENA-Lung02 Phase 3 Trial
September 17, 2024
·
12 min read
Press Releases
Ascletis Enters the Obesity Drug Space with Announcement of Two Ongoing U.S. Phase I Clinical Trials Utilizing Its Small Molecule GLP-1R Agonist ASC30 for Both Once-Monthly Subcutaneous Injection and Once-Daily Oral Tablet for the Treatment of Obesity
September 17, 2024
·
5 min read
Press Releases
BioNTech to Host AI Day as an Edition of its Innovation Series on October 1, 2024
September 17, 2024
·
1 min read
Press Releases
Ferrer Advances Research into Progressive Supranuclear Palsy (PSP) with the Inclusion of the First Participant in a Phase II Clinical Trial
September 17, 2024
·
4 min read
Press Releases
Ossium Health Reports Positive Initial Outcomes for First Ever Leukemia Patient Treated with Organ Donor Derived Bone Marrow
September 17, 2024
·
3 min read
Press Releases
Subgroup Analysis from Pivotal WU-KONG1B Study Exhibits Robust Efficacy of Sunvozertinib in Non-Small Cell Lung Cancer Patients with EGFR Exon 20 Insertion Mutations Across Different Baseline Characteristics
September 17, 2024
·
6 min read
Press Releases
Neo Medical Secures Landmark Equity Investment of $68 million to Accelerate Global Growth in Spine Surgery
September 17, 2024
·
4 min read
Press Releases
Galderma Reaffirms Its Leadership in Dermatology With Extensive Presence at EADV 2024
September 17, 2024
·
5 min read
1 of 82,430
Next